Glaukos Corporation

GKOSNYSEHealthcare● Active

$121.96

$-3.04(-2.43%)

Market Cap$7.2B

P/E Ratio—

52W High$148.11

52W Low$73.16

Avg Volume888K

Open$124.18

Beta0.81

Free Cash Flow Financials Revenue

Glaukos Corporation (GKOS) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

GKOS · free cash flow · updated Jun 8, 2026

Core FCF metrics

GKOS · FCF · TTM · margin & CAGR

Free cash flow was −$54.0M for FY2025 (fiscal year ending 2025-12-31), up 20.1% year-over-year The FCF margin was -10.6%.

FY2025 Free Cash Flow−$54.0M▲ +20.1% YoY

Trailing 12M (TTM)−$18.5Mtrailing 4 quarters sum

FCF Margin-10.6%−$54.0M ÷ revenue

3-Year CAGRN/AN/A — contains negative FCF

5-Year CAGRN/AN/A — contains negative FCF

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

GKOS · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest−$46.3M(8M)−$54.0M▲ +20.1%-10.6%

FY2024−$61.3M(6M)−$67.6M▲ +13.3%-17.6%

FY2023−$57.8M(20M)−$78.0M▼ 23.1%-24.8%

FY2022−$33.1M(30M)−$63.3M▼ 174.5%-22.4%

FY2021$24.7M(48M)−$23.1M▲ +22.9%-7.8%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

GKOS · P/FCF · FCF yield · FCF per share

Glaukos Corporation (GKOS) reported negative free cash flow of −$0.05B. FCF-based valuation ratios are not meaningful when FCF is negative.

FCF Yield (TTM)

N/A

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

N/A

TTM FCF ÷ Shares Outstanding

Price / FCF

N/A

Share Price ÷ FCF per Share

EV / FCF (TTM)

N/A

Enterprise Value basis

FCF-based valuation ratios are only meaningful when free cash flow is positive. Negative FCF indicates capital expenditures exceeded operating cash flow.

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-12-31

Cash flow statement summary

GKOS · cash flow statement · operating / investing / financing

For FY2025, Glaukos Corporation generated −$46.3M in operating cash flow and spent 8M in capital expenditures, yielding −$54.0M in free cash flow.

Operating Activities

−$46.3M

Cash from core business operations

2025-12-31

Investing Activities

−$77.6M

CapEx, acquisitions & investments

2025-12-31

Financing Activities

+$11.9M

Buybacks, dividends & debt

2025-12-31

FCF FormulaOperating CF (−$46.3M) − |CapEx| (8M) = FCF (−$54.0M)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

GKOS vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

Glaukos CorporationYOU

GKOS

−$54.0M+20.1%-10.6%

Loss

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

Glaukos Corporation (GKOS) reported free cash flow of −$54.0M for FY2025 (fiscal year ending 2025-12-31), up 20.1% year-over-year. The FCF margin was -10.6%.

Based on available data, Glaukos Corporation has maintained positive free cash flow for at least 3 fiscal year(s). FCF peaked at $19.2M in FY2017.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

GKOS free cash flow · 8 questions

Glaukos Corporation free cash flow was −$54.0M for FY2025, up 20.1% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at −$18.5M.

GKOS free cash flowGKOS FCFGKOS FCF 2025GKOS free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · Glaukos Corporation · Glaukos Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026